Further Evidence for Early Healing with the SYNERGY™ Stent
How does SYNERGY compare with other stents regarding endothelial cell coverage, endothelial cell function, and thrombogenicity?
% Endothelial Cell (EC) Coverage at 21 Days in Cell Assay
![% Endothelial Cell (EC) Coverage at 21 Days in Cell Assay](https://www.bostonscientific.com/en-EU/medical-specialties/interventional-cardiology/clinical-spotlight/synergy-further-evidence-for-early-healing/_jcr_content/maincontent-par/image.img.cmo-endothelial-cell-coverage.png)
Endothelial Cell (EC) Function
![Endothelial Cell (EC) Function](https://www.bostonscientific.com/en-EU/medical-specialties/interventional-cardiology/clinical-spotlight/synergy-further-evidence-for-early-healing/_jcr_content/maincontent-par/image_0.img.endothelial-cell-function.png)
In a pre-clinical evaluation, SYNERGY displays greater localization of VE-Cadherin at cell junctions indicating improved EC function. Green stain indicates functional endothelial cells.
![Reduced Thrombogenicity with the SYNERGY Stent](https://www.bostonscientific.com/en-EU/medical-specialties/interventional-cardiology/clinical-spotlight/synergy-further-evidence-for-early-healing/_jcr_content/maincontent-par/image_1.img.cmo-reduced-thrombogenicity.png)